CVS Health stock surged over 11% following a sizable revenue beat and the appointment of new CEO David Joyner. See why I'm ...

CVS Health (CVS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Erin Wright from ...

Witnessing a positive shift, the current average has risen by 6.25% from the previous average price target of $64.00. A clear picture of CVS Health's perception among financial experts is painted ...

Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

A number of analysts have downgraded estimates for CVS Health CVS following the pharmacy benefit and retail pharmacy stalwart ...

CVS Health reported mixed third-quarter results as higher medical ... insulin prices Pfizer says drug for deadly cancer ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Before we dive into the specifics of this recent uptick, it’s worth looking at how CVS Health has been performing on a year-to-date (YTD) basis compared to the broader market. As of the most recent ...

CVS Health (CVS) is expected to deliver a year-over-year decline ... it's worth having a handicapping insight into the odds of a positive EPS surprise. This drugstore chain and pharmacy benefits ...

CVS Health’sCVS0.49%increase; green up pointing triangle new chief executive, David Joyner, moved quickly to put his stamp on the company, promising a reorganization and new leadership at Aetna ...